Labiana Health S.A. (LAB) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Labiana Health S.A. (LAB) has a cash flow conversion efficiency ratio of 0.604x as of December 2022. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (€4.68 Million ≈ $5.47 Million USD) by net assets (€7.74 Million ≈ $9.05 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see Labiana Health S.A. (LAB) market capitalisation for the company's overall valuation and market capitalisation.
Labiana Health S.A. - Cash Flow Conversion Efficiency Trend (2021–2025)
This chart illustrates how Labiana Health S.A.'s cash flow conversion efficiency has evolved over time, based on yearly financial data.
Labiana Health S.A. Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Labiana Health S.A. ranked by their cash flow conversion efficiency. Explore LAB operating cash flow to net income to measure how well operating cash flow supports reported net income.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
The Investment Trust Of India Limited
NSE:THEINVEST
|
-0.433x |
|
Wikana SA
WAR:WIK
|
0.073x |
|
Oswal Greentech Limited
NSE:OSWALGREEN
|
N/A |
|
Bilendi
PA:ALBLD
|
0.110x |
|
Payment Financial Technologies Ltd
TA:PMNT
|
0.344x |
|
Gihon Telekomunikasi Indonesia Tbk PT
JK:GHON
|
0.046x |
|
Equus Energy Ltd
AU:EQU
|
-0.161x |
|
CHEET.M.ADR 50 NEW
F:0C9
|
N/A |
Annual Cash Flow Conversion Efficiency for Labiana Health S.A. (2021–2025)
The table below shows the annual cash flow conversion efficiency of Labiana Health S.A. from 2021 to 2025. View LAB stock price for real-time trading data and today's change.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | €4.76 Million ≈ $5.56 Million |
€1.70 Million ≈ $1.99 Million |
0.357x | -87.25% |
| 2024-12-31 | €2.57 Million ≈ $3.00 Million |
€7.19 Million ≈ $8.41 Million |
2.801x | +622.10% |
| 2023-12-31 | €3.40 Million ≈ $3.98 Million |
€-1.83 Million ≈ $-2.13 Million |
-0.536x | -188.78% |
| 2022-12-31 | €7.74 Million ≈ $9.05 Million |
€4.68 Million ≈ $5.47 Million |
0.604x | +78.22% |
| 2021-12-31 | €11.52 Million ≈ $13.47 Million |
€3.91 Million ≈ $4.57 Million |
0.339x | -- |
About Labiana Health S.A.
Labiana Health, S.A. develops, manufactures, sells, and markets animal and human health medicine products in Spain, rest of European Union, North America, and internationally. It offers anesthetics-sedatives, anti-infectives, anti-inflammatories, antiparasitics, hormonals, nutritional products, metabolism regulators, and vitamin products. The company also provides sterile and lyophilized dosage f… Read more